Loading...
Novel IDH1 Mutant Inhibitors for Treatment of Acute Myeloid Leukemia
Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are driver mutations in acute myeloid leukemia (AML) and other cancers. We report the development of new allosteric inhibitors of mutant IDH1. Crystallographic and biochemical results demonstrated that compounds of this chemical series bind t...
Na minha lista:
| Udgivet i: | Nat Chem Biol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5155016/ https://ncbi.nlm.nih.gov/pubmed/26436839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nchembio.1930 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|